News
MGRX
2.553
+3.35%
0.083
Weekly Report: what happened at MGRX last week (1111-1115)?
Weekly Report · 3d ago
Mangoceuticals Signs Consulting Deal with CFO Johnston
TipRanks · 11/12 22:29
Weekly Report: what happened at MGRX last week (1104-1108)?
Weekly Report · 11/11 12:07
Weekly Report: what happened at MGRX last week (1028-1101)?
Weekly Report · 11/04 12:03
Mangoceuticals regains full compliance with Nasdaq min bid price requirement
TipRanks · 10/31 12:15
Weekly Report: what happened at MGRX last week (1021-1025)?
Weekly Report · 10/28 11:53
BUZZ-U.S. STOCKS ON THE MOVE-Freeport-McMoRan, A.O. Smith, Genuine Parts
Reuters · 10/22 18:26
BUZZ-U.S. STOCKS ON THE MOVE-Lockheed Martin, General Motors, Philip Morris International
Reuters · 10/22 15:52
BUZZ-Mangoceuticals to evaluate potential strategic alternatives, shares fall
Reuters · 10/22 13:58
MANGOCEUTICALS SHARES FALL 3.3% ON PLAN TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES
Reuters · 10/22 13:31
BUZZ-Mangoceuticals to evaluate potential strategic alternatives, shares rise
Reuters · 10/22 12:45
Mangoceuticals board initiates process to evaluate strategic alternatives
TipRanks · 10/22 12:26
MangoRx Announces That It Has Initiated A Process To Evaluate Potential Strategic Alternatives With The Intent To Unlock And Maximize Shareholder Value, Including But Not Limited To Potential Mergers, Acquisitions, Divestitures And Business Combinations, Acquisitions Of Businesses, Entry Into New Lines Of Business, Business Expansions, Joint Ventures, And Other Key Strategic Transactions Outside The Ordinary Course Of The Company's Current Business
Benzinga · 10/22 12:20
MANGORX ANNOUNCES FORMATION OF STRATEGY AND ALTERNATIVES COMMITTEE
Reuters · 10/22 12:00
MANGOCEUTICALS INC - BOARD INITIATES STRATEGIC REVIEW TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES
Reuters · 10/22 12:00
Mangoceuticals To Defend Against Eli Lilly's Lawsuit Over Alleged Copying Of Weight-Loss Drugs
NASDAQ · 10/22 03:31
Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit
Seeking Alpha · 10/21 23:12
Mangoceuticals Defends Against Eli Lilly Allegations
TipRanks · 10/21 21:32
Mangoceuticals ‘refutes’ claims by Eli Lilly regarding sale of tirzepatide
TipRanks · 10/21 21:15
Mangoceuticals Says It Learned Earlier This Morning That Eli Lilly Has Filed Lawsuit Claiming That Company Improperly Copied Weight-loss Medicine, Zepbound And Mounjaro; Says It Strongly Refutes Any And All Claims Made By Lilly
Benzinga · 10/21 21:14
More
Webull provides a variety of real-time MGRX stock news. You can receive the latest news about Mangoceuticals, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About MGRX
Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.